We use cookies on this site to enable your digital experience. By continuing to use this site, you are agreeing to our cookie policy. close

Gilead Sues Teva Over Truvada ANDA

Law360 (December 16, 2008, 12:00 AM EST) -- Gilead Sciences Inc. has slapped Teva Pharmaceuticals Industries Ltd. with a patent infringement suit after the Israeli generic-drug maker filed an application to market a generic version of the HIV treatment Truvada.

Gilead filed the lawsuit Friday following Teva's filing of an abbreviated new drug application to market a generic version of Truvada, according to a company statement.

“Gilead has full confidence in the strength of its patent position and plans to vigorously defend the intellectual property rights of Truvada,” the company said in a statement....
To view the full article, register now.